Queen's Award Received in 2021 ISO 9001 Certified Delivered over 1,000,000 bio-reagents to life science researchers Trusted by Life Science Communities
Cart summary

You have no items in your shopping cart.

KRAS G12D inhibitor 7

SKU: orb1690704

Description

KRAS G12D inhibitor 7 is a potent and selective small molecule targeting the oncogenic KRAS G12D mutation. It is a valuable research tool for investigating KRAS-driven tumor biology in both in vitro cellular assays and in vivo xenograft models, supporting the development of targeted cancer therapies.

Research Area

Pharmacology & Drug Discovery, Signal Transduction

Images & Validation

Key Properties

CAS Number2648552-34-3
MW582.709
FormulaC32H38N8O3
SMILESCN1CCC[C@H]1COc1nc2CN(CCc2c(n1)N1CCN([C@@H](CC#N)C1)C(=O)[C@H]1CN1)c1cc(O)cc2ccccc12
TargetKras,Others,Ras

Storage & Handling

Storage-20°C
Expiration Date12 months from date of receipt.
DisclaimerFor research use only

Similar Products

  • KRAS G12D inhibitor 13 [orb1685862]

    2648552-62-7

    589.64

    C31H33F2N7O3

    50 mg, 100 mg, 25 mg
  • SOS1-IN-7 [orb1687119]

    2755415-30-4

    462.46

    C23H25F3N4O3

    50 mg, 100 mg, 25 mg
  • KRAS G12D inhibitor 16 [orb1744952]

    2648221-12-7

    682.59

    C32H39IN6O3

    50 mg, 100 mg, 25 mg
  • TH-Z816 [orb2565164]

    2847881-42-7

    486.65

    C29H38N6O

    50 mg, 25 mg, 100 mg
  • KRAS G12D inhibitor 19 [orb2565898]

    2833695-47-7

    624.68

    C35H34F2N6O3

    50 mg, 10 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Key Properties

No computed properties available.

Protocol Information